WV MSSP Community Health Center Enhanced
Colleen Wagner
ACO Primary Contact
202-802-6634
Locations
Locations

Aledade Accountable Care 12, LLC
4550 Montgomery Ave, Ste 950N
Bethesda, MD 20814
 

ACO Participants ACO Participant in Joint Venture
Belington Community Medical Services Association, Inc N
CAMDEN ON GAULEY MEDICAL CENTER INC N
Change, Incorporated N
Clay-Battelle Health Services Association N
LINCOLN COUNTY PRIMARY CARE CENTER INC N
Monongahela Valley Association of Health Centers, Inc. N
New River Health Association, Inc N
Rainelle Medical Center Inc N
SHENANDOAH VALLEY MEDICAL SYSTEM, INC. N
TUG RIVER HEALTH ASSOCIATION, INC. N
VALLEY HEALTH SYSTEMS, INC N
WESTERN MARYLAND HEALTH CARE CORPORATION N
WIRT COUNTY HEALTH SERVICES ASSOCIATION INC N

First Name Last Name Member's Voting Power (Expressed as a percentage or number) Membership Type Practice Legal Business Name
Rebecca Thomas 1 ACO Participant Representative Clay-Battelle Health Services Association
Nancy Vandergrift 1 ACO Participant Representative Monongahela Valley Association of Health Centers, Inc.
Andrea Cline 1 ACO Participant Representative Tug River Health Assocition, Inc.
Lisa Leach 1 ACO Participant Representative Lincoln County Primary Care Center Inc
Mathew Weimer 1 ACO Participant Representative Valley Health Systems, Inc
Rhonda Krugman 1 ACO Participant Representative Wirt County Health Services Association, Inc
Eric Ruf 1 ACO Participant Representative Belington Community Medical Services Association
Margaret Hickey 1 ACO Participant Representative Camden On Gauley Medical Center Inc
John Schultz 1 ACO Participant Representative New River Health Association, Inc
Kristi Atha-Rader 1 ACO Participant Representative Rainelle Medical Center Inc
Michael Li 1 ACO Participant Representative Shenandoah Valley Medical System, Inc
Lisa Mowry 1 ACO Participant Representative Change, Incorporated
Michelle Dixon 1 ACO Participant Representative Western Maryland Healthcare Corporation
Colleen Wagner 1 Other Aledade, Inc.
Vanessa Chatterton 1 Medicare Beneficiary Representative N/A
  • ACO Executive: Ms. Colleen Wagner
  • Medical Director: Dr. Matthew Weimer
  • Compliance Officer: Ms. Sarah Chasson
  • Quality Assurance/Improvement Officer: Dr. Emily Maxson
  • Beneficiary Engagement Committee: L.J. Fauber, Chair
  • Evidence-Based Medicine Committee: Matthew Weimer, Chair
  • Compliance Committee: Matthew Weimer, Chair
  • Performance Improvement Committee: Steve Shattls, Chair
  • Federally Qualified Health Center (FQHC)

Second Agreement Period 

  • Performance Year 2020, $ 6,184,525
  • Performance Year 2019, $4,259,380

First Agreement Period

  • Performance Year 2019, $4,259,380
  • Performance Year 2018, $0
  • Performance Year 2017, $0

Note: Our ACO participated in multiple performance years during Calendar Year 2019. Shared savings/losses amount reported for Performance Year 2019 therefore represents net shared savings or losses across all performance years in 2019 and is shown under all agreement periods in which the ACO operated during Calendar Year 2019.

Second Agreement Period

  • Performance Year 2020:
    • Proportion invested in infrastructure: 10%
    • Proportion invested in redesigned care processes/resources: 30%
    • Proportion of distribution to ACO participants: 60%
  • Performance Year 2019:
    • Proportion invested in infrastructure: 10%
    • Proportion invested in redesigned care processes/resources: 30%
    • Proportion of distribution to ACO participants: 60%

First Agreement Period 

  • Performance Year 2019:
    • Proportion invested in infrastructure: 10%
    • Proportion invested in redesigned care processes/resources: 30%
    • Proportion of distribution to ACO participants: 60%

Note: Our ACO participated in multiple performance years during Calendar Year 2019. Distribution of shared savings reported for Performance Year 2019 therefore represents the distribution of the net shared savings across all performance years in 2019 and is shown under all agreement periods in which the ACO operated during Calendar Year 2019.

2020 Quality Performance Results
ACO#
Measure Name
Rate
ACO Mean
ACO-8
Risk Standardized, All Condition Readmission
15.22
15.07
ACO-38
Risk-Standardized Acute Admission Rates for Patients with Multiple Chronic Conditions
53.17
49.50
ACO-43
Ambulatory Sensitive Condition Acute Composite (AHRQ* Prevention Quality Indicator (PQI #91))
1.19
0.95
ACO-13
Falls: Screening for Future Fall Risk
55.00
84.97
ACO-14
Preventive Care and Screening: Influenza Immunization
63.12
76.03
ACO-17
Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention
71.83
81.67
ACO-18
Preventive Care and Screening: Screening for Depression and Follow-up Plan
85.81
71.46
ACO-19
Colorectal Cancer Screening
70.53
72.59
ACO-20
Breast Cancer Screening
64.49
74.05
ACO-42
Statin Therapy for the Prevention and Treatment of Cardiovascular Disease
85.28
83.37
ACO-40
Depression Remission at Twelve Months
20.00
15.69
ACO-27
Diabetes Mellitus: Hemoglobin A1c Poor Control
19.48
14.70
ACO-28
Hypertension (HTN): Controlling High Blood Pressure
68.65
72.87

For Previous Years’ Financial and Quality Performance Results, Please Visit data.cms.gov

Payment Rule Waivers

Waiver for Payment for Telehealth Services:

  • Our ACO clinicians provide telehealth services using the flexibilities under 42 CFR § 425.612(f) and 42 CFR § 425.613.
Fraud and Abuse Waivers